Smith+Nephew introduces CORIOGRAPH™ Pre-Op Planning and Modeling Services for Total Hip Arthroplasty
Smith+Nephew (LSE:SN, NYSE:SNN) announces FDA clearance for CORIOGRAPH Pre-Op Planning and Modeling Services for total hip arthroplasty (THA). This innovative planning software, exclusive to CORI Surgical System users, enables both X-ray and CT scan planning for patient-specific outcomes.
The system leverages 15+ years of clinical expertise and over 350,000 image-based hip and knee surgery plans. Key features include advanced modeling capabilities with patient-specific spinopelvic classification, image-agnostic planning with 2D/3D images, and compatibility across Smith+Nephew's hip implant solutions.
The first procedures were completed at Orlando Health Jewett Orthopedic Institute, with surgeons reporting improved accuracy and optimization of component positioning.
Smith+Nephew (LSE:SN, NYSE:SNN) annuncia l'approvazione della FDA per i Servizi di Pianificazione e Modellazione Pre-Operativa CORIOGRAPH per l'artroplastica totale dell'anca (THA). Questo innovativo software di pianificazione, esclusivo per gli utenti del Sistema Chirurgico CORI, consente di effettuare pianificazioni sia con raggi X che con scansioni TC per risultati specifici per il paziente.
Il sistema sfrutta oltre 15 anni di esperienza clinica e più di 350.000 piani chirurgici basati su immagini per interventi di anca e ginocchio. Tra le caratteristiche principali ci sono capacità di modellazione avanzate con classificazione spinopelvica specifica per il paziente, pianificazione indipendente dalle immagini con immagini 2D/3D e compatibilità con le soluzioni di impianto per anca di Smith+Nephew.
I primi interventi sono stati completati presso l'Orlando Health Jewett Orthopedic Institute, con i chirurghi che riportano un miglioramento nella precisione e nell'ottimizzazione del posizionamento dei componenti.
Smith+Nephew (LSE:SN, NYSE:SNN) anuncia la aprobación de la FDA para los Servicios de Planificación y Modelado Preoperatorio CORIOGRAPH para la artroplastia total de cadera (THA). Este innovador software de planificación, exclusivo para los usuarios del Sistema Quirúrgico CORI, permite realizar planificación tanto con rayos X como con tomografías computarizadas para resultados específicos para el paciente.
El sistema aprovecha más de 15 años de experiencia clínica y más de 350.000 planes quirúrgicos basados en imágenes para operaciones de cadera y rodilla. Las características clave incluyen capacidades avanzadas de modelado con clasificación espinopélvica específica para el paciente, planificación independiente de la imagen con imágenes 2D/3D y compatibilidad con las soluciones de implantes de cadera de Smith+Nephew.
Los primeros procedimientos se completaron en el Orlando Health Jewett Orthopedic Institute, con cirujanos que informaron sobre una mejora en la precisión y optimización del posicionamiento de los componentes.
Smith+Nephew (LSE:SN, NYSE:SNN)는 총 고관절 치환술(THA)을 위한 CORIOGRAPH 수술 전 계획 및 모델링 서비스의 FDA 승인을 발표했습니다. 이 혁신적인 계획 소프트웨어는 CORI 수술 시스템 사용자를 위한 독점 소프트웨어로, 환자 맞춤형 결과를 위해 X선 및 CT 스캔 계획 모두를 가능하게 합니다.
이 시스템은 15년 이상의 임상 경험과 350,000개 이상의 이미지 기반 고관절 및 무릎 수술 계획을 활용하고 있습니다. 주요 기능으로는 환자 맞춤형 척추골반 분류를 통한 고급 모델링 기능, 2D/3D 이미지를 사용한 이미지 독립적인 계획, Smith+Nephew의 고관절 임플란트 솔루션과의 호환성이 포함됩니다.
첫 번째 수술은 올랜도 헬스 주바이트 정형외과 연구소에서 완료되었으며, 외과 의사들은 구성 요소 배치의 정확성과 최적화가 향상되었다고 보고했습니다.
Smith+Nephew (LSE:SN, NYSE:SNN) annonce l'approbation de la FDA pour les Services de Planification et de Modélisation Préopératoire CORIOGRAPH pour l'arthroplastie totale de la hanche (THA). Ce logiciel de planification innovant, exclusif aux utilisateurs du Système Chirurgical CORI, permet une planification par rayons X et tomodensitométrie pour des résultats spécifiques au patient.
Le système s'appuie sur plus de 15 ans d'expertise clinique et plus de 350 000 plans chirurgicaux basés sur des images pour des interventions de la hanche et du genou. Les caractéristiques clés comprennent des capacités de modélisation avancées avec une classification spinopelvique spécifique au patient, une planification indépendante de l'image avec des images 2D/3D et une compatibilité avec les solutions d'implants de hanche de Smith+Nephew.
Les premières procédures ont été réalisées à l'Orlando Health Jewett Orthopedic Institute, avec des chirurgiens signalant une amélioration de la précision et de l'optimisation du positionnement des composants.
Smith+Nephew (LSE:SN, NYSE:SNN) gibt die FDA-Zulassung für die CORIOGRAPH Prä-Operationsplanungs- und Modellierungsdienste für die totale Hüftgelenksarthroplastik (THA) bekannt. Diese innovative Planungssoftware, die exklusiv für Benutzer des CORI-Chirurgiesystems verfügbar ist, ermöglicht sowohl Röntgen- als auch CT-Scans für patientenspezifische Ergebnisse.
Das System nutzt über 15 Jahre klinische Expertise und mehr als 350.000 bildbasierte Operationspläne für Hüfte und Knie. Zu den wichtigsten Merkmalen gehören fortschrittliche Modellierungsfähigkeiten mit patientenspezifischer spinopelvischer Klassifikation, bildunabhängige Planungen mit 2D/3D-Bildern und Kompatibilität mit den Hüftimplantatlösungen von Smith+Nephew.
Die ersten Eingriffe wurden am Orlando Health Jewett Orthopedic Institute abgeschlossen, wobei die Chirurgen von einer verbesserten Genauigkeit und Optimierung der Komponentenplatzierung berichteten.
- FDA clearance obtained for new CORIOGRAPH Pre-Op Planning software
- System builds on extensive database of 350,000+ previous surgery plans
- Technology offers flexibility with both X-ray and CT scan compatibility
- Successfully implemented with first procedures completed
- None.
Insights
Smith+Nephew's FDA clearance for CORIOGRAPH Pre-Op Planning and Modeling Services represents a meaningful advancement in orthopedic surgical planning technology. The system's ability to utilize both X-rays and CT scans offers greater flexibility while potentially reducing pre-operative costs when X-rays suffice. The platform's integration with their existing CORI Surgical System strengthens their competitive position in the
The software's unique selling proposition lies in its advanced modeling capabilities, particularly the spinopelvic classification and personalized activity simulation features. This differentiator could help capture market share from competitors like Stryker's Mako and Zimmer Biomet's ROSA. The system's compatibility across Smith+Nephew's entire hip implant portfolio creates a comprehensive ecosystem that could drive increased adoption of their implant products.
Historical data from 350,000+ image-based surgeries provides a robust foundation for the AI/ML algorithms, potentially improving surgical outcomes and reducing revision rates. For investors, this represents a strategic move to capture recurring revenue through software services while protecting their hardware market share.
This product launch strategically positions Smith+Nephew to capitalize on the growing demand for personalized medicine in orthopedics. The dual-imaging capability (X-ray/CT) provides hospitals with cost flexibility, potentially improving adoption rates in price-sensitive markets. Pre-operative planning software can reduce operating room time, which typically costs
The integration with the CATALYSTEM Primary Hip System creates a full-stack solution that could increase customer lock-in and expand profit margins through bundled pricing strategies. Early adopter testimonials from high-profile institutions like Orlando Health Jewett Orthopedic Institute provide credibility and could accelerate market penetration. The focus on activities of daily living in surgical planning aligns with value-based care initiatives, potentially improving reimbursement outcomes.
Latest expansion to the CORI◊ Surgical System portfolio provides a personalized solution for patients and surgeons
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces its CORIOGRAPH Pre-Op Planning and Modeling Services is now cleared for total hip arthroplasty (THA) by the United States Food and Drug Administration. Exclusively for users of the CORI Surgical System, this innovative planning software allows for use of either X-rays or CT scans for planning and modeling, enabling surgeons to make a patient-specific plan for the best possible outcome.
The first procedures using CORIOGRAPH Pre-Op Planning and Modeling Services for Hip with RI.HIP solutions were recently completed by Dr. George Haidukewych, Surgeon in Chief and Academic Chairman at Orlando Health Jewett Orthopedic Institute in Orlando, FL. He stated, “The plan was extremely accurate and provided an opportunity to trial different offsets and combinations prior to surgery. This was invaluable in saving time and optimizing component position and sizing. CT based templating with patient specific impingement modeling is clearly superior to traditional methods of digital templating. It allows for personalization of the surgery to the patient’s specific needs of activities of daily living.”
The CORI Surgical System offers proprietary tools and software across the full suite of procedure solutions to deliver a platform that is flexible and scalable across knee and hip joint arthroplasty indications. Built on 15+ years of clinical expertise and over 350,000 image-based hip and knee surgery plans, CORIOGRAPH Pre-Op Planning and Modeling Services for Hip is designed to optimize implant planning and personalization, including:
- Advanced modeling capabilities that utilize patient specific spinopelvic classification and pelvic tilt go beyond the mechanics of simple range-of-motion to simulate activities of daily living that help surgeons make decisions on optimal implant placement.
- Image-agnostic planning capabilities with 2D and/or 3D images to help personalize the end-to-end care specifically to the patient need.
- Can be used across the entire spectrum of Smith+Nephew hip implant solutions and technologies.
- CORIOGRAPH Pre-Op Planning and Modeling Services combined with RI.HIP solutions and the recently launched CATALYSTEM◊ Primary Hip System, offer a complete solution for primary total hip arthroplasty.
“With the addition of Hip pre-op planning to CORIOGRAPH services, we are now truly personalizing surgery for hip and knee for each patients’ specific needs,” said Craig Gaffin, President of Global Orthopaedics at Smith+Nephew. “I can speak as the business leader and a patient here, as my hip was the first one to be planned with CORIOGRAPH services for Hip. Through the planning process, my surgeon was able to tell what kind of activities I can expect to perform after the surgery based on simulated models of my hip bones.”
To learn more about CORIOGRAPH Pre-Op Planning and Modeling Services and the CORI Surgical System, please visit https://www.smith-nephew.com/en-us/health-care-professionals/products/orthopaedics/coriograph.
- ends –
Media Enquiries
Dave Snyder +1 (978) 749-1440
Smith+Nephew david.snyder@smith-nephew.com
About Smith+Nephew
Smith+Nephew is a portfolio medical technology business focused on the repair, regeneration and replacement of soft and hard tissue. We exist to restore people’s bodies and their self-belief by using technology to take the limits off living. We call this purpose ‘Life Unlimited’. Our 18,000 employees deliver this mission every day, making a difference to patients’ lives through the excellence of our product portfolio, and the invention and application of new technologies across our three global business units of Orthopaedics, Sports Medicine & ENT and Advanced Wound Management.
Founded in Hull, UK, in 1856, we now operate in more than 100 countries, and generated annual sales of
For more information about Smith+Nephew, please visit www.smith-nephew.com and follow us on X, LinkedIn, Instagram or Facebook.
This document is provided for informational purposes and is not intended to serve as medical advice. It is the responsibility of healthcare professionals to determine and utilise the appropriate products and techniques according to their own clinical judgment for each of their patients. The testimonials set out in this document represent the individual's opinions, findings, beliefs, and/or experiences. Individual results will vary. To review the information needed to understand and use CORIOGRAPH safely and effectively, including indications for use, contraindications, precautions, and warnings, please consult the applicable Instructions for Use (IFU) prior to use. Products featured may not be available in individual markets due to regulatory and/or medical practices. Please contact your Smith+Nephew representative if you have questions about availability of Smith+Nephew products in your area.
Forward-looking Statements
This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading profit margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith+Nephew, these factors include: conflicts in Europe and the Middle East, economic and financial conditions in the markets we serve, especially those affecting healthcare providers, payers and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls or other problems with quality management systems or failure to comply with related regulations; litigation relating to patent or other claims; legal and financial compliance risks and related investigative, remedial or enforcement actions; disruption to our supply chain or operations or those of our suppliers; competition for qualified personnel; strategic actions, including acquisitions and disposals, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organisation to adapt to market developments; relationships with healthcare professionals; reliance on information technology and cybersecurity; disruptions due to natural disasters, weather and climate change related events; changes in customer and other stakeholder sustainability expectations; changes in taxation regulations; effects of foreign exchange volatility; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith+Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith+Nephew's most recent annual report on Form 20-F, which is available on the SEC’s website at www. sec.gov, for a discussion of certain of these factors. Any forward-looking statement is based on information available to Smith+Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith+Nephew are qualified by this caution. Smith+Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith+Nephew's expectations.
◊ Trademark of Smith+Nephew. Certain marks registered in US Patent and Trademark Office.
FAQ
What is the new FDA clearance Smith+Nephew (SNN) received for CORIOGRAPH?
How many previous surgery plans support Smith+Nephew's (SNN) CORIOGRAPH system?
What imaging options does Smith+Nephew's (SNN) CORIOGRAPH system support?
Where were the first CORIOGRAPH procedures performed for Smith+Nephew (SNN)?
